Materials for Diabetes Therapeutics
Open Access
- 5 April 2012
- journal article
- review article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 1 (3), 267-284
- https://doi.org/10.1002/adhm.201200037
Abstract
This review is focused on the materials and methods used to fabricate closed‐loop systems for type 1 diabetes therapy. Herein, we give a brief overview of current methods used for patient care and discuss two types of possible treatments and the materials used for these therapies–(i) artificial pancreases, comprised of insulin producing cells embedded in a polymeric biomaterial, and (ii) totally synthetic pancreases formulated by integrating continuous glucose monitors with controlled insulin release through degradable polymers and glucose‐responsive polymer systems. Both the artificial and the completely synthetic pancreas have two major design requirements: the device must be both biocompatible and be permeable to small molecules and proteins, such as insulin. Several polymers and fabrication methods of artificial pancreases are discussed: microencapsulation, conformal coatings, and planar sheets. We also review the two components of a completely synthetic pancreas. Several types of glucose sensing systems (including materials used for electrochemical, optical, and chemical sensing platforms) are discussed, in addition to various polymer‐based release systems (including ethylene‐vinyl acetate, polyanhydrides, and phenylboronic acid containing hydrogels).Keywords
This publication has 181 references indexed in Scilit:
- Integrated carbon fiber electrodes within hollow polymer microneedles for transdermal electrochemical sensingBiomicrofluidics, 2011
- Microencapsulation of islets within alginate/poly(ethylene glycol) gels cross-linked via Staudinger ligationActa Biomaterialia, 2011
- Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitusProceedings of the National Academy of Sciences of the United States of America, 2010
- Accurate Spectroscopic Calibration for Noninvasive Glucose Monitoring by Modeling the Physiological Glucose DynamicsAnalytical Chemistry, 2010
- The Molecular Chaperone α-Crystallin as an Excipient in an Insulin FormulationPharmaceutical Research, 2010
- Hard and soft micro- and nanofabrication: An integrated approach to hydrogel-based biosensing and drug deliveryJournal of Controlled Release, 2010
- An electrically active microneedle array for electroporationBiomedical Microdevices, 2009
- Transdermal drug deliveryNature Biotechnology, 2008
- The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromoleculesBiomaterials, 2008
- In vitro, in vivo and post explantation testing of glucose-detecting biosensors: Current methods and recommendationsBiomaterials, 2007